AstraZeneca stock dives 9% after heart drug trial misses target
2026-07-09
·
via US Top News and Analysis
A late-stage clinical trial failed to miss its primary endpoint, U.K.'s laregst drugmaker said Thursday.
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。